Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection
Megan E. Schmidt, David K. Meyerholz, Steven M. Varga
Mucosal Immunology (2019) Vol. 13, Iss. 3, pp. 507-517
Open Access | Times Cited: 15

Showing 15 citing articles:

Host Responses to Respiratory Syncytial Virus Infection
Ayse Agac, Sophie M. Kolbe, Martin Ludlow, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1999-1999
Open Access | Times Cited: 23
Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection
Katherine M. Eichinger, Jessica L. Kosanovich, Sonal V. Gidwani, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 50
A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
Fabián E. Díaz, Mariana Guerra-Maupome, Paiton O. McDonald, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Distinct roles for type I and type III interferons in virulent human metapneumovirus pathogenesis
Yu Zhang, Jiuyang Xu, Margot Miranda-Katz, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 2, pp. e1011840-e1011840
Open Access | Times Cited: 3
Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity
Clara Maier, Jana Fuchs, Pascal Irrgang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Immunogenicity Evaluation of Respiratory Syncytial Virus Prefusogenic-F Based Virus-like-Particles Consisting of G and M Proteins in Mice
Ahmedali S. Mandviwala, Archana Kulkarni Munje, Anke Huckriede, et al.
(2024)
Open Access | Times Cited: 2
Axl Mediates Resistance to Respiratory Syncytial Virus Infection Independent of Cell Attachment
Dan Zhang, Yuanhui Zhao, Lingling Wang, et al.
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 67, Iss. 2, pp. 227-240
Closed Access | Times Cited: 10
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2
Salvatore Rotundo, Eleonora Vecchio, Antonio Abatino, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 55-64
Open Access | Times Cited: 10
Self‐Assembled Multiepitope Nanovaccine Provides Long‐Lasting Cross‐Protection against Influenza Virus
Jiaojiao Nie, Qingyu Wang, Chenxi Li, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 10
Closed Access | Times Cited: 5
HRSV prefusion-F protein with Adju-Phos adjuvant induces long-lasting Th2-biased immunity in mice
Hai Li, Hu Ren, Yangzi Zhou, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262231-e0262231
Open Access | Times Cited: 3
The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
Lei Huang, Meiqing Liu, Chang-Qing Wan, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 3
Immunoprophylaxis of Respiratory Syncytial Virus Infection: Recent Updates
Nuzhat Umran, Prabu Dhandapani
Indian Journal of Respiratory Care (2024) Vol. 13, Iss. 1, pp. 43-49
Open Access
Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production
Kostlend Mara, Meiling Dai, Aaron M. Brice, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 59-59
Open Access | Times Cited: 1
In silico Approach for B Cell Epitopes Prediction of Respiratory Syncytial Virus
Gayathri Anandhan, Yogesh B. Narkhede, Manikandan Mohan, et al.
International Journal of Peptide Research and Therapeutics (2023) Vol. 29, Iss. 5
Closed Access
An Overview of Respiratory Syncytial Virus Vaccine Development
Shuaibu Abdullahi Hudu, M. A. Saeed
Annals of Clinical and Experimental Medicine (2022) Vol. 3, Iss. 1
Open Access
Page 1

Scroll to top